UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus
Shares of UnitedHealth Group Incorporated dropped roughly 3% on Wednesday, slipping to a session low of $274.04. In after-hours trading, the stock was last down 2.9%, trading at $275.92.
